In this subset, FLMM analysis revealed a unique significant enhancement in mean signal during SG treatment from approximately 7.6 to 5.6 seconds prior to bout termination, relative to no-treatment controls (n = 679 bouts
We also check for low sodium, B12, and ferritincommon hidden causes of mood changes
But research backing these claims is limited
Derosa G, Putignano P, Bossi AC, Bonaventura A, Querci F, Franzetti IG, et al
4,6,20,44 Combination of DPP-4 Inhibitors and GLP-1 Agonists: Because both DPP-4 inhibitors and GLP-1 agonists increase incretin, there has been interest in learning whether this combination could result in a synergistic A1C-lowering effect
Authors and Reviewers Originally written in 2005 by: Jane Higdon, Ph.D